These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8228323)

  • 1. Direct effects of cutaneous neuropeptides on adenylyl cyclase activity and proliferation in a keratinocyte cell line: stimulation of cyclic AMP formation by CGRP and VIP/PHM, and inhibition by NPY through G protein-coupled receptors.
    Takahashi K; Nakanishi S; Imamura S
    J Invest Dermatol; 1993 Nov; 101(5):646-51. PubMed ID: 8228323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMR-106-01, ROS 17/2.8, MC3T3-E1, and Saos-2) and primary bone cells.
    Bjurholm A; Kreicbergs A; Schultzberg M; Lerner UH
    J Bone Miner Res; 1992 Sep; 7(9):1011-9. PubMed ID: 1384276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes.
    Haegerstrand A; Jonzon B; Dalsgaard CJ; Nilsson J
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5993-6. PubMed ID: 2474824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular effects and cyclic AMP production produced by VIP, PHM, PHV, PACAP-27, PACAP-38, and NPY on rabbit ovarian artery.
    Yao W; Sheikh SP; Ottesen B; Jørgensen JC
    Peptides; 1996; 17(5):809-15. PubMed ID: 8844771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidergic modulation of G-protein coupled cyclic-AMP accumulation in the rat caudate nucleus.
    Moser A; Cramer H
    Neuropeptides; 1992 Jul; 22(3):143-7. PubMed ID: 1279450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of functional neuropeptide Y receptors in a human neuroblastoma cell line.
    Gordon EA; Kohout TA; Fishman PH
    J Neurochem; 1990 Aug; 55(2):506-13. PubMed ID: 2164571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y inhibits vasoactive intestinal peptide-stimulated adenylyl cyclase in rat ventral prostate.
    Solano RM; Carmena MJ; Guijarro LG; Prieto JC
    Neuropeptides; 1994 Jul; 27(1):31-7. PubMed ID: 7969818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal polypeptide stimulates the proliferation of HaCaT cell via TGF-alpha.
    Sung KJ; Chang SE; Paik EM; Lee MW; Choi JH
    Neuropeptides; 1999 Dec; 33(6):435-46. PubMed ID: 10657522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mouse T-cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis.
    Boudard F; Bastide M
    J Neurosci Res; 1991 May; 29(1):29-41. PubMed ID: 1653367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitonin gene-related peptide stimulates proliferation of human endothelial cells.
    Haegerstrand A; Dalsgaard CJ; Jonzon B; Larsson O; Nilsson J
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3299-303. PubMed ID: 2159144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
    Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H
    Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin gene-related peptide (CGRP) receptors are linked to cyclic adenosine monophosphate production in SK-N-MC human neuroblastoma cells.
    Van Valen F; Piechot G; Jürgens H
    Neurosci Lett; 1990 Nov; 119(2):195-8. PubMed ID: 2177866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y inhibits beta-adrenergic agonist- and vasoactive intestinal peptide-induced cyclic AMP accumulation in rat pinealocytes through pertussis toxin-sensitive G protein.
    Harada Y; Okubo M; Yaga K; Kaneko T; Kaku K
    J Neurochem; 1992 Dec; 59(6):2178-83. PubMed ID: 1359017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenylyl cyclase stimulation by VIP in rat seminal vesicle membranes.
    Rodriguez-Pena MS; Guijarro LG; Prieto JC
    Peptides; 1991; 12(4):821-4. PubMed ID: 1664946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VIP and the potent analog, stearyl-Nle(17)-VIP, induce proliferation of keratinocytes.
    Granoth R; Fridkin M; Gozes I
    FEBS Lett; 2000 Jun; 475(2):78-83. PubMed ID: 10858492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
    O'Dorisio MS; Wood CL; Wenger GD; Vassalo LM
    J Immunol; 1985 Jun; 134(6):4078-86. PubMed ID: 2985703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase A mediates the modulation of the slow Ca(2+)-dependent K(+) current, I(sAHP), by the neuropeptides CRF, VIP, and CGRP in hippocampal pyramidal neurons.
    Haug T; Storm JF
    J Neurophysiol; 2000 Apr; 83(4):2071-9. PubMed ID: 10758117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin inhibits the growth of human gastric carcinoma cell line KATO III.
    Nakamura A; Yamatani T; Arima N; Yamashita Y; Fujita T; Chiba T
    Regul Pept; 1992 Feb; 37(3):183-94. PubMed ID: 1313594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
    Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
    Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.